abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapelocationmap-pinminusnewsorganisationotheroverviewpluspreviewprofilerefreshnewssearchsecurityPathtagticktooltiptwitteruniversalityweb

This page is not available in اللغة العربية and is being displayed in English

قصة

Oxfam report says top drug companies focusing on patents, not the poor

In November 2007, Oxfam issued a report, "Investing for life: Meeting  poor people's needs for access to medicines through responsible business practices".  In the report, Oxfam examines the business conduct of 12 pharmaceutical companies with respect to access to medicines for the poor.  The Business & Human Rights Resource Centre invited all 12 companies to respond to the report.  The results to date are below (any future responses received will be added to this page).

On 6 February 2008 Oxfam sent a rejoinder, commenting on the company responses: "Oxfam rejoinder" [DOC]

COMPANY RESPONSES / NON-RESPONSES:

Abbott Laboratories statement [DOC]

AstraZeneca statement [DOC]

Bristol-Myers Squibb did not respond

GlaxoSmithKline statement [DOC]

Eli Lilly declined to respond

Johnson & Johnson statement [DOC]

Merck statement [PDF]

Novartis statement [DOC]

Pfizer statement [DOC]
Pfizer's Malaria Platform [DOC]

Roche declined to respond

Sanofi-Aventis statement [PDF] 

Wyeth did not respond

 

Oxfam Gets A Cold Shoulder From Drugmakers, Pharmalot, 5 Feb 2008 (article commenting on Oxfam's report, the companies' responses, and Oxfam's rejoinder)

Drug makers reject Oxfam targets, in Ethical Corporation, Mar 2008 (scroll down to middle of article)

ردود الشركة

Abbott Laboratories عرض الرد
AstraZeneca عرض الرد
Bristol-Myers Squibb

لا جواب

Eli Lilly

لا جواب

GlaxoSmithKline عرض الرد
Johnson & Johnson عرض الرد
Roche

لا جواب

Wyeth (part of Pfizer)

لا جواب

Story Timeline